** Health insurer's shares CNC.N up ~4% at $61.9
** CNC maintains its 2021 adj. earnings forecast of
$5.05-$5.35/shr at the Morgan Stanley's global healthcare
conference
** CFO says co witnessed a rise in inpatient COVID-19
admissions due to the Delta variant, which continued into
August, and spiked after the third week and has begun to settle
and come down at month end
** A fall in non-COVID-19 healthcare costs was adequate for
co to be able to be comfortable to reiterate guidance, CFO says
** Co says it intends on growing adj. EPS modestly in 2022
with acceleration into 2023 and 2024
** Brokerage Stephens says CNC's expectation of modest
earnings growth in 2022, suggests the Street consensus
expectation for 10% growth is likely too aggressive
** CNC down 0.50% YTD
(Reporting by Manojna Maddipatla in Bengaluru)
((manojna.kalyani@thomsonreuters.com; +91 8061822700;))